DA-9805
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DA-9805, covering 2022-05-24 to 2022-05-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of DA-9805 for Parkinson's Disease [Phase 2]